semaglutide being pulled from market An Ongoing Crisis: Shortage Raises Dual Concerns for Obesity and Diabetes Treatment Semaglutide for Weight Loss: How

Alongside the anticipated CV safety of many of these agents, evidence for certain sodiumglucose transporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have revealed potential cardioprotective effects in patients with T2D who are at high risk of CVD events

Considered valuable in ongoing metabolic research programs

Pendulum Life is leading a new era of microbiome-first weight loss support

Wondering if Ozempic and Adderall can be taken together

Always follow your healthcare providers guidance for your personal needs

Peak GLP-1 increases were significantly higher (~32%) after RYGB at both follow-ups (p<0.05)